Chris Warfield is a Clinical Oncology Specialist focused on Lung Oncology at Natera, starting in August 2025. In this role, Chris engages with key opinion leaders across integrated delivery networks to promote the adoption of Signatera MRD for treatment response monitoring in patients with stage I-III NSCLC and those undergoing IO therapy. Prior experience includes leadership positions as Regional Business Director at CIRCULOGENE and extensive sales roles within Medtronic, Olympus Corporation, ZOLL Medical Corporation, Great Lakes Coils, HCR ManorCare, Amedisys, ADVANTAGE HOME HEALTH & HOSPICE, and Cintas. Chris holds a Bachelor of Arts in Business Administration and Management from Adrian College.
This person is not in any teams
This person is not in any offices